These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19155316)

  • 1. The syndrome of gastric carcinoid and hyperparathyroidism: a family study and literature review.
    Christopoulos C; Balatsos V; Rotas E; Karoumpalis I; Papavasileiou D; Kontogeorgos G; Dupasquier S; Calender A; Skandalis N; Economopoulos P
    Eur J Endocrinol; 2009 Apr; 160(4):689-94. PubMed ID: 19155316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.
    Ferolla P; Falchetti A; Filosso P; Tomassetti P; Tamburrano G; Avenia N; Daddi G; Puma F; Ribacchi R; Santeusanio F; Angeletti G; Brandi ML
    J Clin Endocrinol Metab; 2005 May; 90(5):2603-9. PubMed ID: 15713725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients].
    Balogh K; Hunyady L; Patócs A; Valkusz Z; Bertalan R; Gergics P; Majnik J; Toke J; Tóth M; Szucs N; Gláz E; Futo L; Horányi J; Rácz K; Tulassay Z
    Orv Hetil; 2005 Oct; 146(43):2191-7. PubMed ID: 16323565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoid tumors of the stomach: a clinical and radiographic study.
    Binstock AJ; Johnson CD; Stephens DH; Lloyd RV; Fletcher JG
    AJR Am J Roentgenol; 2001 Apr; 176(4):947-51. PubMed ID: 11264084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic carcinoids in multiple endocrine neoplasia type 1.
    Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
    Ann Surg; 1998 Jul; 228(1):99-105. PubMed ID: 9671073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
    Lim LC; Tan MH; Eng C; Teh BT; Rajasoorya RC
    J Intern Med; 2006 Apr; 259(4):428-32. PubMed ID: 16594911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature.
    Christakis I; Busaidy NL; Cote GJ; Williams MD; Hyde SM; Silva Figueroa AM; Kwatampora LJ; Clarke CN; Qiu W; Lee JE; Perrier ND
    Int J Surg; 2016 Jul; 31():10-6. PubMed ID: 27212590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
    Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
    Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing.
    Cardinal JW; Bergman L; Hayward N; Sweet A; Warner J; Marks L; Learoyd D; Dwight T; Robinson B; Epstein M; Smith M; Teh BT; Cameron DP; Prins JB
    J Med Genet; 2005 Jan; 42(1):69-74. PubMed ID: 15635078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman.
    Lou L; Zhou L; Wang W; Li H; Li Y
    BMC Cancer; 2019 Nov; 19(1):1107. PubMed ID: 31727021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
    Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
    Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
    Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel missense mutation of the MEN1 gene in a multiple endocrine neoplasia type 1 patient associated with carcinoid syndrome.
    Ukita C; Yamaguchi M; Tanaka T; Shigeta H; Nishikawa M
    Intern Med; 2003 Nov; 42(11):1112-6. PubMed ID: 14686752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.